Phase 3 Acute Myeloid Leukemia Trial Begins Recruitment
According to a story from globenewswire.com, the biopharmaceutical company SELLAS Life Sciences Group, Inc. just announced that it has started screening participants for its phase 3 clinical trial. The trial…